Literature DB >> 3897677

Cytohistochemical studies on estrogen receptors of breast cancer tissue using an immunoperoxidase technique.

Z Iwasa, K Matsumoto, M Yamato, M Yasutomi.   

Abstract

The estrogen receptors (ER) in breast cancer tissues were investigated in 122 patients using an immunoperoxidase method. ER (+) were evident in 77 of 122 patients (63.1 per cent). If classified according to pre- and postmenopausal subjects. ER (+) was seen in 61.4 per cent and ER (-) in 32.9 per cent before menopause, and ER (+) in 65.4 per cent and ER (-) in 30.8 per cent after menopause with no marked difference between the two. If classified according to histological type, ER (+) was seen in 72.3 per cent of those with papillotubular carcinoma and in 62.0 per cent of those with scirrhous carcinoma, whereas ER (-) was seen in 44.9 per cent of those with medullary tubular carcinoma. ER (+) was seen in carcinoma with apocrine metaplasia, lobular carcinoma and Paget's carcinoma. Concerning the relationship between primary tumors and metastatic lymph nodes, ER (+) for both was seen in 20 of 41 patients (48.8 per cent) whereas ER (-) for both was found in 9 of 41 patients (22.0 per cent). Four patients with local recurrences had a positive ER (+) at the beginning of treatment, but the ER became negative after hormonal treatment and chemotherapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897677     DOI: 10.1007/bf02469886

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  15 in total

1.  Current status of estrogen receptors in human breast cancer.

Authors:  W L McGuire
Journal:  Cancer       Date:  1975-08       Impact factor: 6.860

2.  Fluorescence polarization measurement of the hormone-binding site interaction.

Authors:  S A Levison; W B Dandliker; R J Brawn; W P Vanderlaan
Journal:  Endocrinology       Date:  1976-10       Impact factor: 4.736

3.  Estrogen receptor concentrations in 269 cases of histologically classified human breast cancer.

Authors:  C Silfverswärd; J A Gustafsson; S A Gustafsson; S Humla; B Nordenskjöld; A Wallgren; O Wrange
Journal:  Cancer       Date:  1980-04-15       Impact factor: 6.860

4.  The histopathological evaluation of human breast cancers in correlation with estrogen receptor values.

Authors:  F F Parl; R K Wagner
Journal:  Cancer       Date:  1980-07-15       Impact factor: 6.860

5.  Cancer cell estrogen receptor of human mammary carcinoma.

Authors:  S H Lee
Journal:  Cancer       Date:  1979-07       Impact factor: 6.860

6.  Histochemical assay of estrogen and progesterone receptors in breast cancer: correlation with biochemical assays and patients' response to endocrine therapies.

Authors:  L P Pertschuk; E H Tobin; E Gaetjens; A C Carter; G A Degenshein; N D Bloom; D J Brigati
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

7.  Estrogen receptor and endocrine responsiveness in Japanese versus American breast cancer patients.

Authors:  Y Nomura; S Kobayashi; O Takatani; H Sugano; K Matsumoto; W L McGuire
Journal:  Cancer Res       Date:  1977-01       Impact factor: 12.701

8.  The use of immunocytochemical techniques for the detection of steroid hormones in breast cancer cells.

Authors:  W D Mercer; M E Lippman; T M Wahl; C A Carlson; D A Wahl; D Lezotte; P O Teague
Journal:  Cancer       Date:  1980-12-15       Impact factor: 6.860

9.  PAP immunoperoxidase method demonstrating endogenous estrogen in breast carcinomas.

Authors:  M Shimizu; O Wajima; M Miura; I Katayama
Journal:  Cancer       Date:  1983-08-01       Impact factor: 6.860

10.  Inter-site variation of oestrogen receptors in human breast cancers.

Authors:  W D Tilley; D D Keightley; E L Cant
Journal:  Br J Cancer       Date:  1978-10       Impact factor: 7.640

View more
  1 in total

1.  Estrogen and progesterone receptors in gallbladder cancer.

Authors:  S Nakamura; H Muro; S Suzuki
Journal:  Jpn J Surg       Date:  1989-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.